<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02047279</url>
  </required_header>
  <id_info>
    <org_study_id>14-04-31491</org_study_id>
    <nct_id>NCT02047279</nct_id>
  </id_info>
  <brief_title>Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial Fibrillation</brief_title>
  <acronym>ALARM-vs-AF</acronym>
  <official_title>Left Atrium Reduction Versus no Left Atrium Reduction for Patients With Enlarged Left Atria and Persistent or Long Standing Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate left atrial volume reduction surgery concomitant&#xD;
      with the maze procedure and mitral valve repair/replacement in patients with atrial&#xD;
      fibrillation with an enlarged left atria.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Cox-Maze procedure has been a gold standard for the treatment of atrial fibrillation.&#xD;
      Success of the modified maze procedure after valvular operation with an enlarged left atria&#xD;
      and persistent and longstanding persistent atrial fibrillation remains suboptimal. The&#xD;
      question addressed was: In adults undergoing a maze procedure for atrial fibrillation does&#xD;
      left atrial size reduction compared to maze surgery alone improve maze surgery success?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2014</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from atrial fibrillation</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of significant adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>MVS + maze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure: Maze procedure, mitral valve surgery&#xD;
The scheme of lesion pattern: &quot;box&quot; lesion + line to mitral valve + line from &quot;box&quot; to left atrial appendage. The ablation procedure was performed by using a dry bipolar radiofrequency ablation clamp.&#xD;
The left atrial appendage was excluded in all cases. For mitral regurgitation or stenosis, the procedures will be a valve repair in the majority of cases. For valves that are not amenable to repair, a valve replacement will be performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MVS + maze + LA reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure: maze procedure, mitral valve surgery, left atrial reduction&#xD;
The scheme of lesion pattern: &quot;box&quot; lesion + line to mitral valve + line from &quot;box&quot; to left atrial appendage. The ablation procedure was performed by using a dry bipolar radiofrequency ablation clamp.&#xD;
The left atrial appendage was excluded in all cases. For mitral regurgitation or stenosis, the procedures will be a valve repair in the majority of cases. For valves that are not amenable to repair, a valve replacement will be performed.&#xD;
The enlarged left atria are plicated (suture technique) between the left and right pulmonary vein down to the inferior end of left atrial incision on the half-moon shape.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>maze procedure</intervention_name>
    <description>The scheme of lesion pattern: &quot;box&quot; lesion + line to mitral valve + line from &quot;box&quot; to left atrial appendage. The ablation procedure was performed by using a dry bipolar radiofrequency ablation clamp. The left atrial appendage was excluded in all cases.</description>
    <arm_group_label>MVS + maze</arm_group_label>
    <arm_group_label>MVS + maze + LA reduction</arm_group_label>
    <other_name>surgical ablation</other_name>
    <other_name>radiofrequency ablation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>mitral valve surgery</intervention_name>
    <description>For mitral regurgitation or stenosis, the procedures will be a valve repair in the majority of cases. For valves that are not amenable to repair, a valve replacement will be performed.</description>
    <arm_group_label>MVS + maze</arm_group_label>
    <arm_group_label>MVS + maze + LA reduction</arm_group_label>
    <other_name>mitral valve repair</other_name>
    <other_name>mitral velve replacement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>left atrial reduction</intervention_name>
    <description>The enlarged left atria are plicated (suture technique) between the left and right pulmonary vein down to the inferior end of left atrial incision on the half-moon shape.</description>
    <arm_group_label>MVS + maze + LA reduction</arm_group_label>
    <other_name>left atrial volume reduction</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to sign Informed Consent and Release of Medical Information forms&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Clinical indications for mitral valve surgery for organic mitral valve disease Note:&#xD;
             May include need for surgical management of functional tricuspid regurgitation or&#xD;
             patent foramen ovale. Surgical intervention may be performed via sternotomy or&#xD;
             minimally invasive procedure.&#xD;
&#xD;
          -  a) Persistent atrial fibrillation (AF) within 6 months prior to randomization, defined&#xD;
             as non self-terminating AF lasting greater than 7 days but no more than one year, or&#xD;
             lasting less than 7 days but necessitating pharmacologic or electrical cardioversion.&#xD;
&#xD;
        Duration of AF must be documented by medical history and Presence of AF must be documented&#xD;
        by a direct electrocardiographic assessment within 6 months prior to randomization.&#xD;
&#xD;
        b) Longstanding persistent AF is defined as continuous AF of greater than one year&#xD;
        duration.&#xD;
&#xD;
        Duration of AF must be documented by medical history and Presence of AF must be documented&#xD;
        by a direct electrocardiographic assessment upon arrival in the OR.&#xD;
&#xD;
          -  left atrial diameter &gt; 65mm&#xD;
&#xD;
          -  Able to use heart rhythm monitor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  AF is paroxysmal&#xD;
&#xD;
          -  AF without indication for mitral valve surgery&#xD;
&#xD;
          -  Concomitant coronary artery bypass grafting (CABG), aortic arch or aortic valve&#xD;
             procedure&#xD;
&#xD;
          -  Previous catheter ablation for AF&#xD;
&#xD;
          -  Redo cardiac surgery&#xD;
&#xD;
          -  Left ventricle ejection fraction (LV EF) &lt; 35%&#xD;
&#xD;
          -  Life expectancy of less than one year&#xD;
&#xD;
          -  Mental impairment or other conditions that may not allow subject to understand the&#xD;
             nature, significance, and scope of study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander V Bogachev-Prokophiev, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meshalkin Research Institute of Pathology of Circulation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novosibirsk State Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>January 24, 2014</study_first_submitted>
  <study_first_submitted_qc>January 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2014</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meshalkin Research Institute of Pathology of Circulation</investigator_affiliation>
    <investigator_full_name>Alexander Bogachev-Prokophiev</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Mitral valve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

